Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 33, 2022 - Issue 8
Submit an article Journal homepage
273
Views
0
CrossRef citations to date
0
Altmetric
Review Articles

Risk of fetal malformation, spontaneous abortion, and adverse pregnancy outcomes after gestational terbinafine exposure: a systematic review

Philipp Foessleitnera Department of Obstetrics and Gynecology, Division of Obstetrics and Feto-maternal Medicine, Medical University of Vienna, Vienna, AustriaORCID Iconhttps://orcid.org/0000-0002-8409-1119View further author information
ORCID Icon,
Alex Farra Department of Obstetrics and Gynecology, Division of Obstetrics and Feto-maternal Medicine, Medical University of Vienna, Vienna, AustriaORCID Iconhttps://orcid.org/0000-0002-4628-9052View further author information
ORCID Icon &
Julia Deinsbergerb Department of Dermatology, Medical University of Vienna, Vienna, AustriaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-4237-1526View further author information
ORCID Icon
Pages 3073-3079 | Received 11 Jul 2022, Accepted 03 Aug 2022, Published online: 14 Aug 2022

References

  • El-Gohary M, van Zuuren EJ, Fedorowicz Z, et al. Topical antifungal treatments for tinea cruris and tinea corporis. Cochrane Database Syst Rev. 2014;2014:Cd009992.
  • Fuller LC, Barton RC, Mohd Mustapa MF, et al. British association of dermatologists‘ guidelines for the management of tinea capitis 2014. Br J Dermatol. 2014;171(3):454–463.
  • RYDER NS. Terbinafine: mode of action and properties of the squalene epoxidase inhibition. Br J Dermatol. 1992;126(s39):2–7.
  • Debruyne D, Coquerel A. Pharmacokinetics of antifungal agents in onychomycoses. Clin Pharmacokinet. 2001;40(6):441–472.
  • Bangsgaard N, Saunte DM, Folkenberg M, et al. Serious adverse events reporting on systemic terbinafine: a Danish register-based study. Acta Derm Venereol. 2011;91(3):358–359.
  • Chang CH, Young-Xu Y, Kurth T, et al. The safety of oral antifungal treatments for superficial dermatophytosis and onychomycosis: a meta-analysis. Am J Med. 2007;120(9):791–798.
  • Lipner SR, Scher RK. Onychomycosis: treatment and prevention of recurrence. J Am Acad Dermatol. 2019;80(4):853–867.
  • Filho ST, Cucé LC, Foss NT, et al. Efficacy, safety and tolerability of terbinafine for Tinea capitis in children: Brazilian multicentric study with daily oral tablets for 1,2 and 4 weeks. J Eur Acad Dermatol Venerol. 1998;11(2):141–146.
  • Pharmaceuticals N. Lamasil package insert; [cited 2022 Mar 16]. Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/1999/20846s001lbl.pdf. 2001.
  • Murase JE, Heller MM, Butler DC. Safety of dermatologic medications in pregnancy and lactation: Part I. Pregnancy. J Am Acad Dermatol. 2014;70:401–414. quiz 415. 2014/02/18.
  • Page MJ, Moher D, Bossuyt PM, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021;372:n160. 2021/03/31. DOI
  • Higgins JPT TJ, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editors. Cochrane handbook for systematic reviews of interventions. Chichester (UK): John Wiley & Sons, 2019.
  • Wells GS, O'Connell D, Peterson J, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2022; [cited 2022 Mar 16]. Available from:http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
  • Andersson NW, Thomsen SF, Andersen JT. Exposure to terbinafine in pregnancy and risk of preterm birth, small for gestational age, low birth weight, and stillbirth: a nationwide cohort study. J Am Acad Dermatol. 2021;84(3):763–767.
  • Andersson NW, Thomsen SF, Andersen JT. Evaluation of association between oral and topical terbinafine use in pregnancy and risk of major malformations and spontaneous abortion. JAMA Dermatol. 2020;156(4):375–383.
  • Carter TC, Druschel CM, Romitti PA, et al. Antifungal drugs and the risk of selected birth defects. Am J Obstet Gynecol. 2008;198(2):191.e191–197.
  • Sarkar MR, Koren G. Pregnancy outcome following gestational exposure to terbinafine: a prospective comparative study. Birth Defects Research. 2003;2003:67.
  • Sarkar MR, Koren G. Pregnancy outcome following gestational exposure to terbinafine: a prospective comparative study [abstract]. 2022; [cited 2022 Mar 17]. Available from:10.1002/bdrb.10026.
  • Fleece D, Gaughan JP, Aronoff SC. Griseofulvin versus terbinafine in the treatment of tinea capitis: a meta-analysis of randomized, clinical trials. Pediatrics. 2004;114(5):1312–1315.
  • Sobel JD. Use of antifungal drugs in pregnancy: a focus on safety. Drug Saf. 2000;23(1):77–85.
  • Workowski KA, Bachmann LH, Chan PA, et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep. 2021;70(4):1–187.
  • Foessleitner P, Kiss H, Deinsberger J, et al. Validation of the SavvyCheck™ vaginal yeast test for screening pregnant women for vulvovaginal candidosis: a prospective, cross-sectional study. J Fungi. 2021;7(3):233.
  • Farr A, Effendy I, Frey Tirri B, et al. Guideline: Vulvovaginal candidosis (AWMF 015/072, level S2k). Mycoses. 2021;64(6):583–602.
  • Zhang Z, Zhang X, Zhou YY, et al. The safety of oral fluconazole during the first trimester of pregnancy: a systematic review and meta-analysis. Int J Obstet Gy. 2019;126(13):1546–1552.
  • Liu D, Zhang C, Wu L, et al. Fetal outcomes after maternal exposure to oral antifungal agents during pregnancy: a systematic review and Meta-analysis. Int J Gynaecol Obstet. 2020;148(1):6–13.
  • Abel MK, Murase JE. Oral and topical terbinafine for fungal infections in pregnancy. JAMA Dermatol. 2020;156(4):371–372.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.